Japanese Group To Stop Drug-Induced Disasters
In the wake of the SMON and HIV-contaminated blood disasters in Japan(Marketletters passim), a new private organization has been set up to work exclusively on preventing a recurrence of further drug-induced problems, according to a report in the Japan Times.
To this end, the Yakugai (drug-induced disasters) Ombudsperson Conference has been held, attended by lawyers, medical workers and citizens, who gathered together to analyze information related to drugs, and to urge the Ministry of Health and Welfare, medical institutions and drugmakers to take appropriate steps when something dangerous comes to light.
A representative of SMON victims stressed that it is indispensable for the public to be empowered to watch over the MHW and the drug industry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze